Detalhe da pesquisa
1.
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.
Blood
; 143(14): 1399-1413, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194688
2.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932983
3.
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.
Eur J Haematol
; 110(4): 354-361, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480004
4.
Management of polycythemia vera: A survey of treatment patterns in Italy.
Eur J Haematol
; 110(2): 161-167, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319575
5.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol
; 197(2): 190-200, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137397
6.
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.
Blood
; 136(2): 171-182, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266380
7.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Blood
; 135(5): 381-386, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31869407
8.
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
Ann Hematol
; 100(1): 105-116, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33089365
9.
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
Ann Hematol
; 99(1): 65-72, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832751
10.
Second cancers in MPN: Survival analysis from an international study.
Am J Hematol
; 95(3): 295-301, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816122
11.
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
Hematol Oncol
; 37(4): 424-433, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359447
12.
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
Future Oncol
; 14(26): 2713-2723, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207489
13.
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
Qual Life Res
; 27(6): 1545-1554, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520559
14.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111658
15.
Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy.
Eur J Haematol
; 96(6): 593-601, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26205460
16.
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
Am J Hematol
; 91(7): 692-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060898
17.
Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution.
Virus Evol
; 8(1): veac026, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371557
18.
Clinical challenge for gastroenterologists-Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review.
World J Gastroenterol
; 28(29): 3767-3779, 2022 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36157547
19.
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis.
Cancers (Basel)
; 14(7)2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406571
20.
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.
Blood Adv
; 6(6): 1855-1864, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130339